Deferiprone | Aplastic Anemia and MDS International Foundation

Deferiprone

An iron chelator, this drug is used to remove excess iron from the body. Iron overload (too much iron in the body) can occur in patients who get lots of red blood cell transfusions.
Brand name: 
Ferriprox

Deferiprone comes in a pill form and is taken by mouth. Deferiprone is approved for use in Europe. Researchers in the U.S. are studying deferiprone for treating iron overload in patients with thalassemia. Deferiprone binds with iron in the bloodstream and is removed from the body by the kidneys. Bone marrow failure patients are at risk for developing iron overload if they have had more than 20 units of packed red blood cells.

AAMDSIF does not recommend, endorse, or make any representation about the efficacy, appropriateness or suitability of any drug, treatment or therapy listed on this website. Some therapies listed on our site are considered experimental for the treatment of bone marrow failure diseases. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding any therapy, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.